Splicing alterations that cause resistance to CD19 CAR T-cell therapy identified

Bottom Line: Resistance to CD19 CAR T-cell therapy, a type of immunotherapy that yields long-lasting remissions in many patients with B-cell leukemia, can be caused by CD19 splicing alterations…

Be the first to comment

Leave a Reply

Your email address will not be published.